This notice announces the cancellation of the September 21, 2011 public meeting of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) (‘‘Committee’’) that was published in the July 22, 2011 Federal Register (76
FR 44011 through 44012). This notice also announces a public meeting on Wednesday, March 21, 2012. The Committee generally provides advice and recommendations concerning the adequacy of scientific evidence needed to determine whether certain medical items and services can be covered under the Medicare statute. This meeting will focus on the currently available
evidence regarding antivascular endothelial growth factor (anti-VEGF) treatment of diabetic macular edema (DME). This meeting is open to the public in accordance with the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)).
Received Date:
August 26 2011, at 12:00 AM Eastern Daylight Time
Start-End Page:
53477 - 53478
Page Count:
2
Comment Start Date:
August 26 2011, at 12:00 AM Eastern Standard Time
Comment Due Date:
February 21 2012, at 11:59 PM Eastern Standard Time
Meetings: Medicare Evidence Development and Coverage Advisory Committee
Details Information
Comments
Related Documents